Levitzki and colleagues have used a different strategy to target cells overexpressing EGFR: they use synthetic, double-stranded RNAs (dsRNAs), linked to EGF, to obtain selective and efficient killing of EGFR overexpressing malignant gliomas in vitro and in vivo in a mouse model [6]. Here, EGFR is linked to malignant glioma.